UPDATE: Sterne Agee Upgrades Cardinal Health on New Valuation
November 06, 2013 at 10:16 AM EST
In a report published Wednesday, Sterne Agee analyst Greg T. Bolan upgraded the rating on Cardinal Health (NYSE: CAH ) from Neutral to Buy, and raised the price target from $59.00 to $73.00. In the report, Sterne Agee noted, “After much thought and analysis, we feel it appropriate to raise
